Innovita Biological Technology Co.
Latest round
- Series B
Last raised
- Dec 2018
Total raised
- Undisclosed
Investors
- 6
About Innovita Biological Technology Co.
, Ltd. is a technology company that focuses on the development, production and sales of POCT in vitro diagnostic products. In 2010, the company participated in the formulation of national standards for prenatal and postnatal care testing. In 2015, the company successfully registered respiratory detection products. In 2022, the company was listed on the Shanghai Stock Exchange. Its stock code is 688253. The company's main products include automatic colloidal gold immunochromatography analyzer, triple inspection of respiratory antigens and novel coronavirus (2019-nCoV) antigen detection kits, etc. The fully automatic colloidal gold immunochromatography analyzer is used in conjunction with the appropriate specific reagents based on colloidal gold immunochromatography for quantitative and qualitative analysis of analytes in human samples. The company's products are used in respiratory, cardiovascular and renal function testing fields.
Who invested in Innovita Biological Technology Co.
6 investors across 2 rounds
See all investors in Innovita Biological Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Innovita Biological Technology Co.
Who invested in Innovita Biological Technology Co.?
Innovita Biological Technology Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Innovita Biological Technology Co. raised?
Innovita Biological Technology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Innovita Biological Technology Co. last raise money?
Innovita Biological Technology Co.'s most recent round on record is a Series B, in Dec 2018.
What does Innovita Biological Technology Co. do?
Innovita Biological Technology Co. is a biotechnology company.
Where is Innovita Biological Technology Co. headquartered?
Innovita Biological Technology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Innovita Biological Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Innovita Biological Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Innovita Biological Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.